Royalty Pharma Plc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.3 | 7.0 | 19.9 | 27.2 | 25.6 | 28.0 | 39.1 | 39.3 | 54.7 | 48.2 | 482.0 | 65.9 | 73.0 | 88.3 | 14.9 | 22.7 | 23.4 | 14.7 | 17.5 | 16.5 | 19.8 | 25.8 | 28.0 | 32.5 | 38.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.9 | 7.8 | 9.2 | 12.1 | 11.1 | 9.6 | 10.6 | 10.4 | 11.3 | 10.9 | 9.2 | 9.3 | 7.9 | 7.0 | 7.2 | 8.1 | 7.0 | 7.4 | 6.6 | 7.9 | 8.8 | 8.4 | 9.1 | 11.0 | 12.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.1 | 1.6 | 2.0 | 5.4 | 4.3 | 3.8 | 4.2 | 4.1 | 4.2 | 4.0 | 3.7 | 3.7 | 3.0 | 2.7 | 2.6 | 2.8 | 2.4 | 2.4 | 2.2 | 2.7 | 3.2 | 3.1 | 3.3 | 3.9 | 4.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.7 | 10.0 | 11.5 | 14.5 | 13.2 | 14.9 | 16.0 | 12.7 | 13.5 | 13.6 | 11.6 | 11.4 | 10.0 | 9.2 | 9.6 | 10.5 | 9.7 | 10.3 | 9.6 | 10.8 | 12.0 | 11.8 | 12.6 | 14.4 | 15.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.3 | 6.7 | 13.0 | 16.6 | 14.0 | 19.7 | 25.6 | 20.6 | 27.8 | 27.9 | 61.5 | 33.8 | 35.8 | 38.4 | 12.0 | 17.1 | 17.8 | 12.2 | 13.9 | 12.2 | 14.3 | 17.5 | 18.3 | 20.7 | 23.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.3 | 8.0 | 9.6 | 12.7 | 11.7 | 10.5 | 12.0 | 12.1 | 12.8 | 11.8 | 9.6 | 8.0 | 6.8 | 5.8 | 5.7 | 6.9 | 5.9 | 6.0 | 5.4 | 6.7 | 8.4 | 8.2 | 8.7 | 10.1 | 10.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.8% | 12.5% | 10.5% | 7.9% | 8.6% | 9.5% | 8.3% | 8.2% | 7.8% | 8.5% | 10.4% | 12.4% | 14.8% | 17.1% | 17.7% | 14.4% | 16.9% | 16.7% | 18.4% | 15.0% | 11.9% | 12.2% | 11.5% | 9.9% | 9.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 89.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 144.6% | 135.8% | 136.3% | 130.2% | 75.2% | 66.7% | 80.4% | 69.6% | 62.5% | 62.4% | 46.6% | 42.0% | 13.7% | 24.0% | 18.5% | 17.1% | 63.4% | 42.0% | 42.9% | 68.1% | 57.1% | 83.9% | 79.8% | 65.2% | 65.6% | 67.9% | 62.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 129.4% | 109.2% | 121.2% | 110.8% | 45.9% | 44.3% | 43.4% | 34.2% | 27.1% | 26.4% | 20.6% | 22.6% | 1.9% | 14.1% | 10.8% | 7.9% | 48.2% | 35.7% | 30.1% | 50.5% | 37.9% | 48.3% | 44.3% | 32.6% | 32.4% | 33.9% | 32.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 91.9% | 90.7% | 96.1% | 97.0% | 95.9% | 95.2% | 95.3% | 91.6% | 88.1% | 85.7% | 88.3% | 91.8% | 95.8% | 115.2% | 116.5% | 119.8% | 126.9% | 117.0% | 119.3% | 123.5% | 122.3% | 119.3% | 104.4% | 102.4% | 104.7% | 108.8% | 117.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 38.5% | 39.8% | 56.4% | 22.7% | 9.9% | 19.9% | 16.9% | 13.5% | 10.7% | 10.4% | 7.7% | 8.2% | 0.8% | 5.6% | 4.1% | 3.0% | 17.4% | 12.3% | 10.4% | 16.7% | 12.4% | 16.3% | 16.1% | 11.9% | 11.9% | 12.0% | 11.9% | |
| – | – | – | – | – | – | – | – | – | -362.2% | – | – | – | 18.9% | 15.3% | 14.9% | 10.4% | 4.6% | 6.1% | 5.9% | 4.4% | 3.5% | 3.5% | 2.6% | 2.9% | 0.3% | 1.9% | 1.5% | 1.2% | 6.9% | 5.0% | 3.8% | 6.3% | 4.7% | 6.2% | 5.6% | 4.0% | 3.9% | 4.2% | 4.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 5,992 | 5,333 | 3,468 | 4,458 | 4,990 | 5,361 | 4,752 | 12,192 | 12,447 | 5,310 | 4,998 | 6,120 | 5,406 | 5,146 | 4,953 | 5,195 | 5,658 | 5,296 | 5,837 | 6,657 | 6,683 | 6,530 | 7,371 | 8,010 | 8,332 | 8,370 | 8,150 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 2.2 | 2.2 | 1.2 | 1.5 | 2.7 | 2.8 | 2.2 | 7.0 | 8.7 | 3.8 | 4.6 | 5.6 | 12.8 | 6.4 | 7.5 | 9.3 | 3.0 | 3.9 | 4.8 | 3.5 | 4.3 | 3.2 | 3.8 | 5.1 | 5.1 | 4.9 | 4.7 | |
| 91.2% | 90.6% | 86.4% | 87.1% | 82.1% | 78.4% | 69.6% | 30.2% | -5.3% | -34.0% | – | – | – | 49.0% | 38.6% | 26.5% | 45.9% | 46.9% | 30.7% | 34.7% | 32.7% | 33.0% | 33.2% | 34.0% | 34.8% | 33.5% | 34.9% | 36.7% | 38.7% | 39.8% | 40.3% | 36.7% | 38.1% | 38.1% | 38.0% | 34.6% | 33.2% | 33.0% | 34.8% | 34.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | 1.2 | 1.4 | 0.6 | 0.6 | 1.2 | 1.0 | 2.4 | 2.4 | 1.2 | 1.2 | 1.2 | 1.3 | 1.2 | 1.1 | 1.0 | 0.9 | 0.9 | 1.2 | 1.1 | 1.1 | 1.1 | 1.3 | 1.4 | 1.4 | 1.3 | 1.3 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | -0.04 | – | – | – | 6.67 | 5.85 | 6.62 | 6.01 | 2.51 | 1.60 | 1.60 | 1.29 | 1.02 | 0.99 | 0.77 | 0.83 | 0.08 | 0.55 | 0.42 | 0.31 | 1.89 | 1.34 | 1.13 | 1.93 | 1.46 | 1.89 | 1.82 | 1.37 | 1.38 | 1.48 | 1.46 | |
| – | – | – | – | – | – | – | – | – | 0.00 | – | – | – | 5.15 | 5.36 | 5.46 | 5.43 | 5.47 | 3.61 | 3.69 | 3.76 | 3.77 | 3.75 | 3.72 | 3.70 | 4.28 | 3.88 | 3.90 | 3.87 | 3.91 | 3.75 | 3.75 | 3.82 | 3.84 | 3.92 | 4.10 | 4.20 | 4.25 | 4.36 | 4.55 | |
| 0.12 | 0.10 | 0.07 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 12.85 | – | – | 17.33 | 14.72 | 11.74 | 26.48 | 25.50 | 8.04 | 9.44 | 9.54 | 9.51 | 9.52 | 9.93 | 10.13 | 10.77 | 9.80 | 10.37 | 10.21 | 10.84 | 10.88 | 10.85 | 11.58 | 11.79 | 11.57 | 11.29 | 11.46 | 11.57 | 12.31 | 12.27 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 4.73 | 4.86 | 5.25 | 5.26 | 5.24 | 3.44 | 3.51 | 3.45 | 3.32 | 3.21 | 3.29 | 3.40 | 4.10 | 4.48 | 4.54 | 4.63 | 4.96 | 4.38 | 4.47 | 4.72 | 4.70 | 4.67 | 4.28 | 4.30 | 4.45 | 4.74 | 5.34 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.